Streetbeat News

Analyst Ratings

VRTX

RBC Capital analyst Brian Abrahams has maintained a 'Sector Perform' rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raised the price target from $343 to $348.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:29 am

C

FCNCA

Citigroup analyst Keith Horowitz has initiated coverage on First Citizens BancShares (NASDAQ:FCNCA) with a Neutral rating and a price target of $1520.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:28 am

AGCO

JP Morgan analyst Tami Zakaria maintains an Overweight rating on AGCO (NYSE:AGCO) and raises the price target from $155 to $157.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:26 am

FOLD

JP Morgan analyst Anupam Rama maintains an Overweight rating on Amicus Therapeutics (NASDAQ:FOLD) and raises the price target from $17 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:25 am

TRMB

JP Morgan analyst Tami Zakaria maintains a Neutral rating on Trimble (NASDAQ:TRMB) and raises the price target from $59 to $62.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:22 am

WOOF

Wolfe Research analyst Greg Badishkanian has initiated coverage on Petco Health and Wellness (NASDAQ:WOOF) with a Peer Perform rating.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:22 am

NCNO

Scotiabank analyst Nick Altmann maintains an Outperform rating on Ncino (NASDAQ:NCNO) and raises the price target from $32 to $36.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:20 am

VIV

Itau BBA analyst Carlos de Legarreta has reinstated Telefonica Brasil (NYSE:VIV) with an Outperform rating and announced a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:20 am

NUS

Citigroup analyst Chasen Bender has maintained a Neutral rating on Nu Skin Enterprises (NYSE:NUS) but lowered the price target from $30 to $23.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:18 am

KMX

Stephens & Co. analyst Daniel Imbro has maintained an Equal-Weight rating on CarMax (NYSE:KMX) and lowered the price target from $78 to $70.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:16 am